Rating History for Allos Therapeutics (ALTH) by Brean Capital

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/10/2012 N/A Downgrade Neutral
(N/A)
N/A
(N/A)
1.81
(1.84)
1.66% Details